Department of Biomedical and Specialty Surgical Sciences, University of Ferrara, Ferrara, Italy.
Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
J Cell Physiol. 2021 Jan;236(1):641-652. doi: 10.1002/jcp.29891. Epub 2020 Jun 24.
Bone mineralization is an orchestrated process by which mineral crystals are deposited by osteoblasts; however, the detailed mechanisms remain to be elucidated. The presence of P2X7 receptor (P2X7R) in immature and mature bone cells is well established, but contrasting evidence on its role in osteogenic differentiation and deposition of calcified bone matrix remains. To clarify these controversies in the present study, we investigated P2X7R participation in bone maturation. We demonstrated that the P2X7R is expressed and functional in human primary osteoblasts, and identified in the P2RX7 promoter several binding sites for transcription factors involved in bone mineralization. Of particular interest was the finding that P2X7R expression is enhanced by nuclear factor of activated T cells cytoplasmic 1 (NFATc1) overexpression, and accordingly, NFATc1 is recruited at the P2RX7 gene promoter in SaOS2 osteoblastic-like cells. In conclusion, our data provide further insights into the regulation of P2X7R expression and support the development of drugs targeting this receptor for the therapy of bone diseases.
骨矿化是一个由成骨细胞沉积矿晶体的协调过程;然而,其详细机制仍有待阐明。P2X7 受体(P2X7R)在未成熟和成熟骨细胞中的存在已得到充分证实,但关于其在成骨分化和钙化骨基质沉积中的作用仍存在相互矛盾的证据。为了解决目前研究中的这些争议,我们研究了 P2X7R 在骨成熟中的作用。我们证明 P2X7R 在人原代成骨细胞中表达并具有功能,并在 P2RX7 启动子中鉴定出了几个参与骨矿化的转录因子结合位点。特别有趣的是,我们发现 P2X7R 的表达可以被激活 T 细胞核因子 1(NFATc1)过表达增强,并且相应地,NFATc1 会募集到 SaOS2 成骨样细胞中的 P2RX7 基因启动子上。总之,我们的数据提供了对 P2X7R 表达调控的进一步了解,并支持开发针对该受体的药物来治疗骨疾病。